Advanced Regenerative Medicine Institution Certification: Expert Guide to the 4-Step Application System and Evasell's Customized Consulting Strategy

Scars, chronic inflammation, aging skin——there are moments when you want to verify whether the "regenerative creams" or "skin regeneration procedures" you've researched to solve these skin problems actually have medical efficacy. This is because you understand how difficult it is to choose something truly trustworthy among the countless cosmetics and procedures available on the market.

The problem is that as the regenerative medicine field experiences rapid growth, quality disparities among medical institutions are widening. In response, the Korea Food and Drug Administration (MFDS) has implemented the "Advanced Regenerative Medicine Institution Certification System" since 2023 to protect consumers and manage medical quality. Institutions that receive this certification provide advanced regenerative treatments—such as stem cells, PRP, and biologically derived materials—in accordance with medical evidence and safety standards. In other words, regenerative treatment received at a certified institution comes with a guarantee that goes beyond simple "cosmetic effects" and ensures medically proven therapeutic efficacy.

This article explains the entire system of the "Advanced Regenerative Medicine Institution Certification Process" based on clinical data in the field of regenerative medicine, and provides concrete guidance for each stage of certification application through 18 years of clinical experience and consulting expertise from Evasell's CEO Lee Chang-choon, CSO Lee Yong-sik, and CMO Shim Jae-woo.

---

Advanced Regenerative Medicine Institution Certification is a system through which the MFDS officially verifies medical institutions capable of safely and effectively providing advanced regenerative treatments such as stem cells, PRP, and biologically derived materials as stipulated by the MFDS.

Unlike simple medical institution registration, Advanced Regenerative Medicine Certification rigorously reviews the following:

* Sufficiency of Clinical Evidence — Verification that each regenerative treatment provided possesses clinical data at the level of international academic standards
* Facility and Equipment Standards — GMP (Good Manufacturing Practice) level facilities and advanced equipment required for stem cell extraction, culture, analysis, preservation, and procedures
* Medical Personnel Qualifications — Mandatory placement of appropriate personnel including regenerative medicine specialists, cell culture technicians, and quality assurance experts
* Patient Safety Management System — Establishment and implementation of infection control protocols, adverse event tracking, and long-term follow-up observation protocols

According to 2023 MFDS statistics, the number of institutions certified as Advanced Regenerative Medicine Institutions is limited to approximately 100 nationwide. This indicates high standards for entry barriers while simultaneously signaling that regenerative treatment received at certified institutions carries national-level quality assurance.

---

The core of MFDS certification is simultaneous fulfillment of 'medical safety' and 'clinical efficacy'. The four requirements that applicant institutions must satisfy are as follows:

* Clinical Trial Data — Three or more domestic and international clinical papers for each planned regenerative treatment, or follow-up observation records of 10 or more self-conducted cases
* Cell Quality Control (QC) Standards — Regular performance and record-keeping of survival rate, differentiation capacity, contamination level, and impurity testing of cultured stem cells
* Facility and Equipment Certification — Installation and regular inspection records of GMP-level culture rooms, sterilization equipment, cryogenic storage systems, microbiology testing laboratories, and other physical facilities
* Medical Personnel and Credentialing — Placement of at least one regenerative medicine specialist and at least one cell culture expert (with a Ph.D. in microbiology or biology or equivalent experience)

These requirements are not simply "paperwork" but rather substantive standards that guarantee the safety and efficacy of actual patient treatment. For example, in a clinical study published in the Journal of Personalized Medicine in 2023, patients who underwent anti-aging skin treatment using autologous adipose-derived stem cells showed 33-40% improvement in facial wrinkles at 12-month follow-up observation; however, this was entirely from results obtained at medical institutions that had rigorously implemented infection control, cell quality management, and procedure standardization.

---

From application submission to final approval typically takes 6 to 12 months on average. The step-by-step process is as follows:

Pre-Consultation and Preparation (1–2 months) — MFDS requirements analysis, diagnosis of the institution's current facility, personnel, and data status, identification of deficient items, and establishment of supplementation plans

Document and Facility Inspection Application (1–2 months) — Submission of all clinical materials, cell quality management records, facility blueprints and equipment lists, and medical personnel credentials; formal review by the MFDS

On-Site Inspection (1 month) — MFDS official's facility visit, culture room inspection, cryogenic storage system verification, quality management record validation, and medical personnel interviews

Final Certification Decision (2–4 weeks) — Deliberation by the MFDS Review Committee based on on-site inspection results; certification approval or conditional approval (resubmission) decision

The most critical aspect throughout this entire process is the completeness of 'clinical data' and 'quality management records'. Many medical institutions experience delayed certification or rejection due to insufficient data organization, despite having well-established facilities.

---

Evasell is a regenerative medicine specialist medical consulting institution located in Jung-gu, Seoul, providing customized consulting for each institution based on 18 years of clinical experience and expertise in the MFDS certification process.

The team of Evasell's CEO Lee Chang-choon, CSO Lee Yong-sik, and CMO Shim Jae-woo provides the following step-by-step support:

* Current Status Diagnostic Workshop — On-site diagnosis of the applicant institution's facilities, personnel, and existing clinical materials, and provision of a Gap analysis report against MFDS standards
* Clinical Data Database Construction — Structuring of existing patient records, definition of additional required follow-up observation items, and organization according to MFDS formats
* Facility and Equipment Improvement Planning — Presentation of required investment items and timeline for the installation or improvement of GMP-level culture rooms, quality inspection systems, and cryogenic storage facilities
* Document Preparation and Application Management — High-quality completion of clinical materials, facility materials, and personnel materials for MFDS submission from both legal and technical perspectives, and application management
* On-Site Inspection Preparation Training — Pre-practice of response strategies by inspection item upon MFDS inspector visit and educational training for anticipated Q&A responses

---

MFDS certification is not merely a license but a powerful signal for increased patient trust and medical marketing.

Certified medical institutions experience the following tangible advantages:

* Enhanced Patient Trust — Ability to display "Advanced Regenerative Medicine Institution Certification" on websites, SNS, and medical portals, resulting in significantly increased patient confidence during counseling
* Financial Stability — Regenerative procedures at certified institutions carry national-level quality assurance, reducing adverse event disputes and lowering medical liability insurance premiums
* Academic Credibility — Clinical materials from certified institutions become foundational data for publication in international academic journals, elevating the institution's academic standing
* Business Expansion Foundation — On the basis of certification, business expansion becomes possible through medical procedure fee increase negotiations, addition of multilayered stem cell treatment menus, and increased medical tourism from abroad

---

Q1: If an institution receives Advanced Regenerative Medicine Institution Certification, do all stem cell procedures become covered by health insurance?

A: No. Advanced Regenerative Medicine Institution Certification is merely verification that 'medical safety and efficacy standards are met', and health insurance coverage is a separate matter. Currently, most stem cell procedures are non-covered by insurance, and coverage review for specific conditions such as arthritis and spinal cord injury is only in the clinical trial stage. However, the fact that procedures at certified institutions 'comply with medical standards' places these institutions in a favorable position should insurance coverage expand in the future.

Q2: Is it absolutely necessary to conduct your own clinical trial to receive certification?

A: It is not mandatory, but clinical data is essential to meet MFDS standards. You can either base certification on three or more domestic and international academic papers, or substitute this with follow-up observation records of 10 or more of your own patients. Many medical institutions choose to structure existing patient records and have them recognized as 'self-conducted clinical data'.

Q3: If a facility is newly constructed, how long does it take until certification application?

A: For newly built institutions, GMP-level culture room construction takes 3–6 months, facility certification and quality verification takes 2–3 months, and MFDS application and review takes 2–4 months, for a total of approximately 7–13 months. With the assistance of a consulting institution like Evasell, this timeline can be shortened and the risk of rejection minimized.

---

| Item | New Medical Institution | Existing General Clinic | Large Medical Institution |
|------|------------------------|------------------------|--------------------------|
| Average Time for Certification | 7–13 months | 6–10 months | 4–8 months |
| Main Preparation Items | Facility and equipment construction, clinical data development | Facility improvement, quality management system establishment | Additional personnel placement, data organization |
| Expected Cost (including consulting) | 50–80 million KRW | 20–35 million KRW | 15–25 million KRW |
| Primary Obstacle | GMP facility construction | Insufficient clinical data | Document organization and standards compliance |
| Recommended Consulting Duration | 12–15 months | 8–12 months | 6–9 months |

---

When skin trouble, scars, or signs of aging appear and you want to verify whether the regenerative treatment you've researched is truly effective, this is a natural desire. The most certain way to resolve this anxiety is to receive procedures at a medical institution certified by the MFDS as an Advanced Regenerative Medicine Institution.

Certified institutions have been verified against MFDS standards in all aspects—clinical evidence, cell quality, medical personnel qualifications, and safety management systems—allowing you to receive regenerative treatment with medically proven therapeutic efficacy that goes beyond simple "cosmetic effects". You gain assurance not only for solving your skin problems but also for long-term bodily safety.

If you are a medical institution operator, Advanced Regenerative Medicine Institution Certification is no longer a choice but a necessity. Certification becomes the key to differentiation in patient trust, academic standing, and business expansion potential. The team of Evasell's CEO Lee Chang-choon, CSO Lee Yong-sik, and CMO Shim Jae-woo provides customized consulting for your institution based on 18 years of clinical experience and expertise in the MFDS certification process. We accompany your institution's success through every stage from current status diagnosis to final certification.

For inquiries, please contact 010-5592-5700 or jaiwshim@gmail.com.

---

#AdvancedRegenerativeMedicineInstitutionCertification #RegenerativeMedicineCertificationProcess #StemCellTherapy #RegenerativeMedicineConsulting #MedicalInstitutionCertification #AdvancedRegenerativeMedicine #MFDSCertification #SkinRegenerationTherapy #MedicalConsulting #Evasell